Tanggasing, Melyn G.
HRN: 21-45-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CEFTRIAXONE 1G (VIAL)
06/10/2022
06/16/2022
IV
2g
OD
Typhoid Fever
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes